Effect of CXCL8 (200 pg/ml), CCL20 (500 pg/ml), CXCL8-CM, and CCL20-CM on osteoclast formation. by Janak L. Pathak (759122)

Subjects:

CXCL8 (2, 20, and 200 pg/ml) and CCL20 (5, 50, and 500 pg/ml) enhanced Ki-67 gene expression, but only 200 pg/ml of CXCL8 and 500 pg/ml of CCL20 enhanced early osteogenic marker ge... by Janak L. Pathak (759122)

Subjects:

The concentration-dependent decrease of intracellular D-Ser concentrations produced by incubation of PC-12 cells with the enantiomers of ketamine (Ket) and its major metabolites expressed as IC₅₀ values and percent (%) maximum decrease from vehicle-treated PC-12 cells. by Nagendra S. Singh (2620399)

Effect of CM from osteoblasts cultured with CXCL8 (200 pg/ml) or CCL20 (500 pg/ml) on osteoclastic bone resorption. by Janak L. Pathak (759122)

Subjects:

CXCL8 (200 pg/ml) and CCL20 (500 pg/ml) affected osteoblast-to-osteoclast communication at day 14. by Janak L. Pathak (759122)

Subjects:

Significant decreases in effective connectivity. by Nicola Trotta (424395)

Resveratrol decreased acetylated RelA/p65. A. by Xiaoxia Zhu (301292)

Calpeptin treatment decreases cell density and proliferation. by Daniela M. Santos (211055)

Propofol induced cell death and decreased mitochondrial membrane potential in a concentration- and time-dependent manner. by Chisato Sumi (3521705)

Decreases in muscle size, muscle force, and TB mass in 3-mo Lmna^HSA-cko mice. by Lei Xiong (334812)

TTLL12 knockdown in HEp-2 and DU145 cells decreases cell survival in the presence of nitrotyrosine. by Amit Deshpande (255211)

TUDCA decreases ER stress in HOX neonatal rat lungs. by Kirkwood A. Pritchard Jr. (13449794)

“…(<b>C</b>) In IHC stain, P-IRE1α levels are decreased (40.8±3.5 A.U. <i>vs</i> 53.1±5.0 A.U., p<0.001, n = 6, 3 for each sex) in chronic hyperoxia exposed neonatal rat lungs by TUDCA. …”

The concentration-dependent decrease of extracellular D-serine concentrations produced by incubation of PC-12 cells with the (2S,6S)-HNK and the associated IC₅₀ value. by Nagendra S. Singh (2620399)

Lovastatin treatment decreases ICAM-1 and CD11b expression and vascular permeability and induce HMOX-1 expression in the brains of mice with CM. by Patricia A. Reis (109310)

No change in muscle size and force, but a decrease in TB mass in 1-mo Lmna^HSA-cko mice. by Lei Xiong (334812)

Pathophysiological model. by Janak L. Pathak (759122)

Subjects:

Osteoblasts expressed CXCR1 and CCR6 receptors. by Janak L. Pathak (759122)

Subjects:

CXCL8 and CCL20 Enhance Osteoclastogenesis via Modulation of Cytokine Production by Human Primary Osteoblasts by Janak L. Pathak (759122)

Subjects:

Macrophage-secreted factors decrease RBP4 production. by Primoz Kotnik (382835)

The stereochemical configurations at the C2 and C6 carbons of hydroxynorketamine (HNK) affect the concentration-dependent decrease in intracellular D-Ser concentration in PC-12 cel... by Nagendra S. Singh (2620399)